HOME Top Market Reports Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: June 2018
Report Code: MD 4870

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global transplant diagnostics market is expected to reach USD 4.91 billion by 2023 from USD 3.25 billion in 2017, at a CAGR of 7.4%.

Years considered for the study are as follows:

  • Base Year: 2017
  • Forecast Period: 2018–2023

Objectives of the study are:

  • To define, describe, segment, and forecast the transplant diagnostics market on the basis of technology, product, transplant type, application, end user, and region
  • To provide detailed information regarding the major factors influencing global market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global market
  • To analyze growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for leading market players
  • To forecast the size of market segments with respect to four main regions, namely, North America (US and Canada), Europe [Germany, France, UK, and Rest of Europe (RoE)], Asia Pacific [China, India, Japan, and Rest of Asia Pacific (RoAPAC)], and the Rest of the World (RoW)
  • To profile the key market players active in the global transplant diagnostics industry and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product developments & commercialization, acquisitions, market expansions, and agreements & collaborations in the transplant diagnostics market

This research study involves the extensive usage of secondary sources, directories, and databases (such as World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), World Bank, International Electrotechnical Commission, U.S. Census Bureau, Centers for Disease Control and Prevention (CDC) The Transplantation Society, American Organ Transplantation Society (US), American Society of Transplantation (US), and National Kidney Foundation), in order to identify and collect information useful for this technical, market-oriented, and financial study of the transplant diagnostics market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

Transplant Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

In 2017, Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US) held the leading position in the global transplant diagnostics market. In the past three years, these companies adopted product developments & commercialization, acquisitions, market expansions, and agreements, partnerships & collaborations as their key business strategies to ensure market dominance. bioMιrieux (France), Becton, Dickinson and Company (US), Merck KGAA (Germany), Hologic (US), and Luminex (US) are some of the other major players in this market.

Stakeholders

  • Transplant diagnostics product manufacturing companies
  • Healthcare service providers (including hospitals, transplant centers, and blood transfusion centers)
  • Blood, tissue, and stem cell banks
  • Government organizations
  • Independent associations and regulatory authorities
  • R&D companies
  • Independent reference laboratories
  • Diagnostic laboratories
  • Clinical research organizations
  • Research laboratories and academic institutes

Scope of the Report

This report categorizes the global market into the following segments and subsegments:

Global Transplant Diagnostics market, by Technology

  • Molecular Assay Technologies
  • PCR-Based Molecular Assay Technologies
    • Real-Time PCR
    • Sequence-Specific Primer-PCR (SSP-PCR)
    • Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
    • Other PCR Technologies
  • Sequencing-Based Molecular Assay Technologies
    • Sanger Sequencing
    • Next-Generation Sequencing (NGS)
    • Other Sequencing Technologies
  • Non-Molecular Assay Technologies

Global Transplant Diagnostics market, by Products & Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

Global Transplant Diagnostics market, by Transplant Type

  • Solid Organ Transplantation
    • Kidney
    • Liver
    • Lung
    • Heart
    • Pancreas
    • Other Organs
  • Stem Cell Transplantation
  • Soft Tissue Transplantation

Global Transplant Diagnostics market, by Application

  • Diagnostic Application
  • Pre-Transplantation
    • Infectious Diseases Testing
    • Histocompatibility Testing
    • Blood Profiling
  • Post-Transplantation
  • Research Application

Global Transplant Diagnostics Market, by End Users

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

Global Transplant Diagnostics market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • China
    • India
    • Japan
    • RoAPAC
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global market report:

Product Analysis

  • Product Matrix which gives a detailed comparison of the product portfolios of the top five global players

Geographical Analysis

  • Further breakdown of the Rest of Europe market into Poland, Italy, Spain, and other countries
  • Further breakdown of the RoW market into the Middle East, Latin America, and Africa

Company Information

  • Detailed analysis and profiling of additional global players (Up to 5 OEMs)

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Major Market Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
           2.1.2 Primary Data
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Procedure Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 36)
    4.1 Transplant Diagnostics Market Overview
    4.2 Market, By Technology
    4.3 Regional Analysis: Market, By Application
    4.4 Asia Pacific: Market, By End User, 2018
    4.5 Regional Analysis: Market, By Product & Service
    4.6 Regional Analysis: Market, By Transplant Type
    4.7 Transplant Diagnostics Market, By Country

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Increasing Number of Transplant Procedures
                    5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
                    5.2.1.3 Increasing Public-Private Funding for Target Research Activities
                    5.2.1.4 Growing Burden of Infectious Diseases
           5.2.2 Key Market Restraints
                    5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays
                    5.2.2.2 Limited Reimbursements for Target Procedures
           5.2.3 Key Market Opportunities
                    5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
                    5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries
           5.2.4 Key Market Challenges
                    5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
                    5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Product and Services (Page No. - 52)
    6.1 Introduction
    6.2 Reagents and Consumables
    6.3 Instruments
    6.4 Software and Services

7 Transplant Diagnostics Market, By Technology (Page No. - 58)
    7.1 Introduction
    7.2 Molecular Assays
           7.2.1 PCR-Based Molecular Assays
                    7.2.1.1 Real-Time PCR
                    7.2.1.2 Sequence-Specific Primer-PCR
                    7.2.1.3 Sequence-Specific Oligonucleotide-PCR
                    7.2.1.4 Other PCR-Based Molecular Assays
           7.2.2 Sequencing-Based Molecular Assays
                    7.2.2.1 Sanger Sequencing
                    7.2.2.2 Next-Generation Sequencing
                    7.2.2.3 Other Sequencing Molecular Assays
    7.3 Non-Molecular Assays

8 Transplant Diagnostics Market, By Transplant Type (Page No. - 78)
    8.1 Introduction
    8.2 Solid Organ Transplantation
           8.2.1 Kidney Transplantation
           8.2.2 Liver Transplantation
           8.2.3 Heart Transplantation
           8.2.4 Lung Transplantation
           8.2.5 Pancreas Transplantation
           8.2.6 Other Organ Transplantations
    8.3 Stem Cell Transplantation
    8.4 Soft Tissue Transplantation

9 Transplant Diagnostics Market, By Application (Page No. - 90)
    9.1 Introduction
    9.2 Diagnostic Applications
           9.2.1 Pre-Transplantation Diagnostics
                    9.2.1.1 Infectious Disease Testing
                    9.2.1.2 Histocompatibility Testing
                    9.2.1.3 Blood Profiling
           9.2.2 Post-Transplantation Diagnostics
    9.3 Research Applications

10 Transplant Diagnostics Market, By End User (Page No. - 101)
     10.1 Introduction
     10.2 Independent Reference Laboratories
     10.3 Hospitals & Transplant Centers
     10.4 Research Laboratories & Academic Institutes

11 Transplant Diagnostics Market, By Region (Page No. - 108)
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 UK
             11.3.3 France
             11.3.4 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 152)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Scenario
             12.3.1 Key Product Launches and Enhancements (2014 to 2018)
             12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018)
             12.3.3 Major Acquisitions (2014 to 2018)
             12.3.4 Key Expansions (2014 to 2018)

13 Company Profiles (Page No. - 157)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 Introduction
     13.2 Becton, Dickinson and Company
     13.3 Biofortuna
     13.4 Biomιrieux SA
     13.5 Bio-Rad Laboratories
     13.6 Caredx
     13.7 F. Hoffman-La Roche Limited
     13.8 Gendx
     13.9 Hologic
     13.10 Illumina
     13.11 Immucor
     13.12 Luminex
     13.13 Merck KGaA
     13.14 Omixon
     13.15 Qiagen
     13.16 Thermo Fisher Scientific

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 211)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Introducing RT: Real-Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports
     14.6 Author Details


List of Tables (122 Tables)

Table 1 Public-Private Investments and Research Grants for the Development of Transplant Diagnostic Products, 2015–2018
Table 2 Cost of Assays for Major NGS/PCR-Based Genomic Tests in Europe (As of 2014)
Table 3 Medical Reimbursements for Transplantation Procedures in the US (2017)
Table 4 Transplant Diagnostics Market, By Product & Services, 2016–2023 (USD Million)
Table 5 Market for Reagents and Consumables, By Region, 2016–2023 (USD Million)
Table 6 Market for Instruments, By Region, 2016–2023 (USD Million)
Table 7 Market for Software and Services, By Region, 2016–2023 (USD Million)
Table 8 Market, By Technology, 2016–2023 (USD Million)
Table 9 Market for Molecular Assays, By Type, 2016–2023 (USD Million)
Table 10 Market for Molecular Assays, By Region, 2016–2023 (USD Million)
Table 11 Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 12 Market for PCR-Based Molecular Assays, By Product, 2016–2023 (USD Million)
Table 13 Market for PCR-Based Molecular Assays, By Application, 2016–2023 (USD Million)
Table 14 Market for PCR-Based Molecular Assays, By End User, 2016–2023 (USD Million)
Table 15 Market for PCR-Based Molecular Assays, By Region, 2016–2023 (USD Million)
Table 16 Market for Real-Time PCR, By Region, 2016–2023 (USD Million)
Table 17 Market for Sequence-Specific Primer-PCR, By Region, 2016–2023 (USD Million)
Table 18 Transplant Diagnostics Market for Sequence-Specific Oligonucleotide-PCR, By Region, 2016–2023 (USD Million)
Table 19 Market for Other PCR-Based Molecular Assays, By Region, 2016–2023 (USD Million)
Table 20 Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 21 Market for Sequencing-Based Molecular Assays, By Product, 2016–2023 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By Application, 2016–2023 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By End User, 2016–2023 (USD Million)
Table 24 Market for Sequencing-Based Molecular Assays, By Region, 2016–2023 (USD Million)
Table 25 Market for Sanger Sequencing, By Region, 2016–2023 (USD Million)
Table 26 Market for Next-Generation Sequencing, By Region, 2016–2023 (USD Million)
Table 27 Market for Other Sequencing Molecular Assays, By Region, 2016–2023 (USD Million)
Table 28 Transplant Diagnostics Market for Non-Molecular Assays, By Product, 2016–2023 (USD Million)
Table 29 Market for Non-Molecular Assays, By Application, 2016–2023 (USD Million)
Table 30 Market for Non-Molecular Assays, By End User, 2016–2023 (USD Million)
Table 31 Market for Non-Molecular Assays, By Region, 2016–2023 (USD Million)
Table 32 Market, By Transplant Type, 2016–2023 (USD Million)
Table 33 Solid Organ Transplantation Market, By Type, 2016–2023 (USD Million)
Table 34 Solid Organ Transplantation Market, By Region, 2016–2023 (USD Million)
Table 35 Kidney Transplantation Market, By Region, 2016–2023 (USD Million)
Table 36 Liver Transplantation Market, By Region, 2016–2023 (USD Million)
Table 37 Heart Transplantation Market, By Region, 2016–2023 (USD Million)
Table 38 Lung Transplantation Market, By Region, 2016–2023 (USD Million)
Table 39 Pancreas Transplantation Market, By Region, 2016–2023 (USD Million)
Table 40 Other Organ Transplantations Market, By Region, 2016–2023 (USD Million)
Table 41 Stem Cell Transplantation Market, By Region, 2016–2023 (USD Million)
Table 42 Soft Tissue Transplantation Market, By Region, 2016–2023 (USD Million)
Table 43 Transplant Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 44 Market for Diagnostic Applications, By Type, 2016–2023 (USD Million)
Table 45 Market for Diagnostic Applications, By Region, 2016–2023 (USD Million)
Table 46 Transplant Diagnostics Market for Pre-Transplantation Diagnostics, By Type, 2016–2023 (USD Million)
Table 47 Market for Pre-Transplantation Diagnostics, By Region, 2016–2023 (USD Million)
Table 48 Transplant Diagnostics Market for Infectious Disease Testing, By Region, 2016–2023 (USD Million)
Table 49 Market for Histocompatibility Testing, By Region, 2016–2023 (USD Million)
Table 50 Market for Blood Profiling, By Region, 2016–2023 (USD Million)
Table 51 Market for Post-Transplantation Diagnostics, By Region, 2016–2023 (USD Million)
Table 52 Transplant Diagnostics Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 53 Market, By End User, 2016–2023 (USD Million)
Table 54 Market for Independent Reference Laboratories, By Region, 2016–2023 (USD Million)
Table 55 Transplant Diagnostics Market for Hospitals & Transplant Centers, By Region, 2016–2023 (USD Million)
Table 56 Market for Research Laboratories & Academic Institutes, By Region, 2016–2023 (USD Million)
Table 57 Transplant Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 58 Total Number of Solid Organ Transplantations Across Key Countries (2016)
Table 59 North America: Transplant Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 60 North America: Market, By Technology, 2016–2023 (USD Million)
Table 61 North America: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 62 North America: Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 63 North America: Market, By Product and Services, 2016–2023 (USD Million)
Table 64 North America: Transplant Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 65 North America: Market, By Transplant Type, 2016–2023 (USD Million)
Table 66 North America: Transplant Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 67 US: Market, By Technology, 2016–2023 (USD Million)
Table 68 US: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 69 US: Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 70 Canada: Transplant Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 71 Canada: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 72 Canada: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 73 Europe: Market, By Country, 2016–2023 (USD Million)
Table 74 Europe: Transplant Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 75 Europe: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 76 Europe: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 77 Europe: Transplant Diagnostics Market, By Product and Services, 2016–2023 (USD Million)
Table 78 Europe: Market, By Application, 2016–2023 (USD Million)
Table 79 Europe: Market, By Transplant Type, 2016–2023 (USD Million)
Table 80 Europe: Market, By End User, 2016–2023 (USD Million)
Table 81 Germany: Transplant Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 82 Germany: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 83 Germany: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 84 Organ Transplantations Performed in the UK, 2013 vs 2015
Table 85 UK: Market, By Technology, 2016–2023 (USD Million)
Table 86 UK: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 87 UK: Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 88 France: Transplant Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 89 France: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 90 France: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 91 RoE: Market, By Technology, 2016–2023 (USD Million)
Table 92 RoE: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 93 RoE: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 94 Asia Pacific: Market, By Country, 2016–2023 (USD Million)
Table 95 Asia Pacific: Market, By Technology, 2016–2023 (USD Million)
Table 96 Asia Pacific: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 97 Asia Pacific: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 98 Asia Pacific: Market, By Product and Services, 2016–2023 (USD Million)
Table 99 Asia Pacific: Transplant Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 100 Asia Pacific: Market, By Transplant Type, 2016–2023 (USD Million)
Table 101 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 102 Japan: Market, By Technology, 2016–2023 (USD Million)
Table 103 Japan: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 104 Japan: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 105 Organ Transplantations Performed in China, 2013 vs 2015
Table 106 China: Market, By Technology, 2016–2023 (USD Million)
Table 107 China: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 108 China: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 109 India: Market, By Technology, 2016–2023 (USD Million)
Table 110 India: Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 111 India: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 112 Solid-Organ Transplantations Performed in the RoAPAC, 2013 vs 2016
Table 113 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 114 RoAPAC: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 115 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 116 RoW: Transplant Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 117 RoW: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 118 RoW: Market for Sequencing-Based Molecular Assays, By Type, 2016–2023 (USD Million)
Table 119 RoW: Transplant Diagnostics Market, By Product and Services, 2016–2023 (USD Million)
Table 120 RoW: Market, By Application, 2016–2023 (USD Million)
Table 121 RoW: Market, By Transplant Type, 2016–2023 (USD Million)
Table 122 RoW: Transplant Diagnostics Market, By End User, 2016–2023 (USD Million)


List of Figures (47 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global Transplant Diagnostics Market
Figure 3 Market Size Estimation: Market
Figure 4 Data Triangulation Methodology
Figure 5 Reagents and Consumables Segment to Account for the Largest Share of the Market in 2023
Figure 6 Sequence-Specific Oligonucleotides-PCR Segment Will Continue to Dominate the Transplant Diagnostics Market in 2023
Figure 7 Solid Organ Transplantation Segment to Account for the Largest Share of the Market in 2018
Figure 8 Infectious Disease Testing Segment to Account for the Largest Share of the Market in 2018
Figure 9 Independent Reference Laboratories Segment to Register the Highest Growth During the Forecast Period
Figure 10 Geographical Snapshot of the Market
Figure 11 Growth in Transplantation Procedures to Drive the Demand for Transplant Diagnostic Products Till 2023
Figure 12 PCR-Based Molecular Assays to Dominate the Market, By Technology, During the Forecast Period
Figure 13 Infectious Disease Testing and Histocompatibility Testing Segments to Witness High Growth in the Asia Pacific Market
Figure 14 Independent Reference Laboratories Will Dominate the Asia Pacific Transplant Diagnostics End-User Market in 2018
Figure 15 North America is Estimated to Be the Largest Market for All Products & Services Segments in the Transplant Diagnostics Market in 2018
Figure 16 Kidney Transplantation Segment to Dominate the Market During the Forecast Period
Figure 17 China and India is Estimated to Be the Fastest-Growing Transplant Diagnostics Market
Figure 18 Transplant Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Solid Organ Transplantation Procedures Performed Across Major Countries, 2016
Figure 20 Reagents & Consumables to Dominate the Market During the Forecast Period (2018–2023)
Figure 21 PCR-Based Molecular Assays Segment to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 22 Kidney Segment to Account for the Largest Share of the Market in 2018
Figure 23 Infectious Disease Testing to Dominate the Market During the Forecast Period
Figure 24 Independent Reference Laboratories to Register the Highest CAGR in the Transplant Diagnostics Market During 2018–2023
Figure 25 North America: Market Snapshot (2018–2023)
Figure 26 Solid-Organ Transplantations Performed in the Us, 2013–2017
Figure 27 Tissue Transplantations Performed in the Us, 2013–2017
Figure 28 Solid-Organ Transplantations Performed in Canada, 2015 vs 2016
Figure 29 Europe: Transplant Diagnostics Market Snapshot (2018–2023)
Figure 30 Asia Pacific: Market Snapshot (2018–2023)
Figure 31 Solid-Organ Transplantations Performed in Japan, 2013 to 2017
Figure 32 RoW: Transplant Diagnostics Market Snapshot (2018–2023)
Figure 33 Product Launches and Enhancements, Key Growth Strategies Adopted By Market Players From 2014 to 2018
Figure 34 Bio-Rad Laboratories Held the Leading Position in the Global Transplant Diagnostics Market as of 2017
Figure 35 Geographic Revenue Mix of the Top Five Market Players (2017)
Figure 36 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 37 Biomerieux: Company Snapshot (2017)
Figure 38 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 39 Caredx: Company Snapshot (2017)
Figure 40 F. Hoffman-La Roche Limited: Company Snapshot (2017)
Figure 41 Hologic: Company Snapshot (2017)
Figure 42 Illumina: Company Snapshot (2017)
Figure 43 Immucor: Company Snapshot (2016)
Figure 44 Luminex: Company Snapshot (2017)
Figure 45 Merck KGaA: Company Snapshot (2017)
Figure 46 Qiagen: Company Snapshot (2017)
Figure 47 Thermo Fisher Scientific: Company Snapshot (2017)

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. The growth witnessed by transplant diagnostics is mainly driven by the increasing public-private funding for target research activities, growing burden of infectious diseases, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products.

Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables.

On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation.

Based on application, the market is categorized into diagnostic and research applications. The diagnostic applications segment accounted for the largest share of the market in 2018. The rising incidence of chronic diseases (that often lead to transplantation in critical and terminal patients) and greater risk of genetic disorders and pathogenic infections after transplantation (due to weaker immunity in geriatric recipients and discovery of novel biomarkers to identify genetic disorders) are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications.

Based on end user, the market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching, growing number of organ transplantation procedures, and growing inauguration & accreditation of diagnostic laboratories across emerging as well as developed countries.

This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.

Transplant Diagnostics Market

Factors such as high procedural cost of NGS and PCR-based diagnostic assays and limited reimbursements for target procedures are expected to restrain the growth of the market during the forecast period.

The major players in the market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and bioMerieux SA (France).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement


-
Request for FREE Sample of this report Send Request